Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 01/08/2007


Featured Articles

-Gastrointestinal Health: Products Designed to Support Digestion, GI Comfort, GI Integrity, Detoxification, Microflora Balance and Motility…*

-Digestion and Digestive Enzymes…*

-Anti-Fatigue Complex Product Information Sheet

New Products

-GI Health

-Fatigue Support

-Resveratrol EXTRA

Product Highlights

-Read more about our weekly product specials

-CoQ10 – NOW 15% LESS

Featured Abstracts

-Resveratrol has the potential to promote healthy glucose metabolism, mitochondrial health, motor function and lifespan as suggested in one study involving mice fed high-calorie diets…*

-Supplemental magnesium may help maintain healthy C-reactive protein metabolism…*

-Acetyl-l-carnitine relieves occasional mental fatigue and promotes mental focus…*

-Optimal zinc serum levels are associated with healthy T cell activation and antioxidant support in individuals experiencing symptoms of occasional fatigue…*

-Aloe supports immune and cellular health throughout the gastrointestinal tract…*

-Curcuma longa extract maintains healthy histamine response, moderates gastric secretions and protects gastric mucosa…*

Frequently Asked Questions

-Is there a difference between forms of magnesium chelates?

Quick Fact

-A note on Resveratrol




Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome

OBJECTIVES: We compared the effects of acetylcarnitine, propionylcarnitine and both compounds on the symptoms of chronic fatigue syndrome (CFS). METHODS: In an open, randomized fashion we compared 2 g/d acetyl-L-carnitine, 2 g/d propionyl-L-carnitine, and its combination in 3 groups of 30 CFS patients during 24 weeks. Effects were rated by clinical global impression of change. Secondary endpoints were the Multidimensional Fatigue Inventory, McGill Pain Questionnaire, and the Stroop attention concentration test. Scores were assessed 8 weeks before treatment; at randomization; after 8, 16, and 24 weeks of treatment; and 2 weeks later. RESULTS: Clinical global impression of change after treatment showed considerable improvement in 59% of the patients in the acetylcarnitine group and 63% in the propionylcarnitine group, but less in the acetylcarnitine plus propionylcarnitine group (37%). Acetylcarnitine significantly improved mental fatigue (p =.015) and propionylcarnitine improved general fatigue (p =.004). Attention concentration improved in all groups, whereas pain complaints did not decrease in any group. Two weeks after treatment, worsening of fatigue was experienced by 52%, 50%, and 37% in the acetylcarnitine, propionylcarnitine, and combined group, respectively. In the acetylcarnitine group, but not in the other groups, the changes in plasma carnitine levels correlated with clinical improvement. CONCLUSIONS: Acetylcarnitine and propionylcarnitine showed beneficial effect on fatigue and attention concentration. Less improvement was found by the combined treatment. Acetylcarnitine had main effect on mental fatigue and propionylcarnitine on general fatigue. Vermeulen RC, Scholte HR. Psychosom Med. 2004 Mar-Apr;66(2):276-82.


For educational purposes only. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure